According to a recent study, patients with cystic fibrosis (CF) appeared to have antibody responses that were comparable to those seen in the general population after...
According to a press release from Vertex Pharmaceuticals, the FDA has increased the use of elexacaftor, tezacaftor, and ivacaftor in children with cystic fibrosis who are...
